Fracture healing in HIV-positive populations

Area of Science:

• Orthopedics
• Infectious Diseases
• Bone Biology

Background:

• Highly active anti-retroviral therapy (HAART) has shifted HIV management towards chronic disease care.
• Emphasis is now placed on non-AIDS-defining complications, including bone health.
• Osteoporosis and fragility fractures are more prevalent in HIV-infected individuals.

Purpose of the Study:

• To review current evidence associating HIV infection with poor fracture healing.
• To explore potential mechanisms linking HIV to compromised bone repair.
• To highlight the clinical implications for fracture management in HIV patients.

Main Methods:

• Literature review of existing studies on HIV infection and fracture healing.
• Analysis of molecular and biochemical hypotheses for impaired bone repair in HIV.
• Consideration of confounding factors affecting fracture outcomes in HIV patients.

Main Results:

• Evidence suggests a direct association between HIV infection and delayed fracture healing.
• HIV may impede bone remodeling, alter cytokine levels (e.g., TNF-alpha), and impair bone vascularity.
• Factors like low BMI, poor nutrition, HAART, and surgical avoidance complicate outcomes.

Conclusions:

• Sound molecular and biochemical evidence supports a direct link between HIV and impaired fracture healing.
• Optimizing fracture management for HIV patients requires further investigation.
• Understanding these mechanisms can reduce patient morbidity and improve resource allocation.